Clostridium difficile infections: Do we know the real dimensions of the problem?

International Journal of Antimicrobial Agents

Volumn 42, Issue SUPPL.1, 2013, Pages

  Tattevin, Pierre ^a,b   Buffet Bataillon, Sylvie ^a   Donnio, Pierre Yves ^a   Revest, Matthieu ^a   Michelet, Christian ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Clostridium difficile; Diagnostic tests; Enzyme immunoassay; Glutamate dehydrogenase; PCR; Toxin B

Indexed keywords

ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; ENZYME IMMUNOASSAY; EUROPE; HEALTH SURVEY; HUMAN; INCIDENCE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; UNITED STATES;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DIARRHEA; HUMANS; INCIDENCE; WORLD HEALTH;

EID: 84879082408     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.04.009     Document Type: Article

References (23)

1. C.P. Kelly, and J.T. LaMont Clostridium difficile - more difficult than ever N Engl J Med 359 2008 1932 1940
2. D.N. Gerding Clostridium difficile 30 years on: what has, or has not, changed and why? Int J Antimicrob Agents 33 Suppl. 1 2009 S2 S8
3. L.C. McDonald, G.E. Killgore, A. Thompson, R.C. Owens Jr., S.V. Kazakova, and S.P. Sambol An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2005 2433 2441
4. F.C. Lessa, C.V. Gould, and L.C. McDonald Current status of Clostridium difficile infection epidemiology Clin Infect Dis 55 Suppl. 2 2012 S65 S70
5. M. Warny, J. Pepin, A. Fang, G. Killgore, A. Thompson, and J. Brazier Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Lancet 366 2005 1079 1084
6. M.P. Hensgens, E.C. Keessen, M.M. Squire, T.V. Riley, M.G. Koene, and E. de Boer Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 18 2012 635 645
7. J.M. Hirshon, A.D. Thompson, B. Limbago, L.C. McDonald, M. Bonkosky, and R. Heimer Clostridium difficile infection in outpatients, Maryland and Connecticut, USA, 2002-2007 Emerg Infect Dis 17 2010 1946 1949
8. P.K. Kutty, C.W. Woods, A.C. Sena, S.R. Benoit, S. Naggie, and J. Frederick Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA Emerg Infect Dis 16 2010 197 204
9. D.N. Gerding Global epidemiology of Clostridium difficile infection in 2010 Infect Control Hosp Epidemiol 31 Suppl. 1 2010 S32 S34
10. M. Rupnik, M.H. Wilcox, and D.N. Gerding Clostridium difficile infection: new developments in epidemiology and pathogenesis Nat Rev Microbiol 7 2009 526 536
11. J.G. Bartlett, and D.N. Gerding Clinical recognition and diagnosis of Clostridium difficile infection Clin Infect Dis 46 Suppl. 1 2008 S12 S18
12. D.M. Musher, and C. Stager Diagnosis of Clostridium difficile infection Clin Infect Dis 54 2012 1675 1676
13. M.J. Crobach, O.M. Dekkers, M.H. Wilcox, and E.J. Kuijper European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI) Clin Microbiol Infect 15 2009 1053 1066
14. S.H. Cohen, D.N. Gerding, S. Johnson, C.P. Kelly, V.G. Loo, and L.C. McDonald Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
15. Y. Longtin, S. Trottier, G. Brochu, B. Paquet-Bolduc, C. Garenc, and V. Loungnarath Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program Clin Infect Dis 56 2013 67 73
16. J.L. Leslie, S.H. Cohen, J.V. Solnick, and C.R. Polage Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing? Eur J Clin Microbiol Infect Dis 31 2012 3295 3299
17. L. Alcalá, A. Martín, M. Marín, M. Sánchez-Somolinos, P. Catalán, and T. Peláez The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect 18 2012 E204 E213
18. M.P. Bauer, D.W. Notermans, B.H. van Benthem, J.S. Brazier, M.H. Wilcox, and M. Rupnik Clostridium difficile infection in Europe: a hospital-based survey Lancet 377 2011 63 73
19. F. Barbut, G. Jones, and C. Eckert Epidemiology and control of Clostridium difficile infections in healthcare settings: an update Curr Opin Infect Dis 24 2011 370 376
20. M.H. Wilcox, N. Shetty, W.N. Fawley, M. Shemko, P. Coen, and A. Birtles Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England Clin Infect Dis 55 2012 1056 1063
21. Health Protection Agency Results from the mandatory surveillance of Clostridium difficile infection 2012 HPA
22. G. Birgand, K. Blanckaert, A. Carbonne, B. Coignard, F. Barbut, and C. Eckert Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, 2006-2007 and associated clusters in 2008-2009 Euro Surveill 15 2010 pii: 19597
23. M.P. Hensgens, A. Goorhuis, D.W. Notermans, B.H. van Benthem, and E.J. Kuijper Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in The Netherlands Euro Surveill 14 2009 pii: 19402